ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Net income

KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967)

Market cap
¥446B
P/E ratio
42.5x
Kobayashi Pharmaceutical makes healthcare products and consumer goods like deodorizers and oral care items, serving domestic and international markets through 40 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Dec 31, 20253,660-63.66%
Dec 31, 202410,071-50.48%
Dec 31, 202320,338+1.58%
Dec 31, 202220,022+1.56%
Dec 31, 202119,715+2.66%
Dec 31, 202019,205+0.34%
Dec 31, 201919,139+6.19%
Dec 31, 201818,023+13.62%
Dec 31, 201715,863+10.77%
Dec 31, 201614,321+6.35%
Mar 31, 201613,466+8.18%
Mar 31, 201512,448+15.22%
Mar 31, 201410,804-15.92%
Mar 31, 201312,849+28.73%
Mar 31, 20129,981

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat